Re: Whitlock's decision - an analysis
Fiona van Iersel
MSc Marketing — King's College London
Module: Marketing Communications (7QQMO520X)
Date: 14 March 2026
https://keats.kcl.ac.uk/mod/forum/discuss.php?d=822653

Re: Whitlock's decision - an analysis
Submitted: 14 March 2026 9:52 PM

Anastasia, you make a good point about transparency and the risk that sending free products to bloggers without disclosure could mislead readers. Disclosure is clearly important in influencer marketing.. but, from a legal perspective the issue may be less about the existence of incentives and more about whether the relationship is transparent and whether the endorsement reflects genuine experience.

Under guidance from the Federal Trade Commission, endorsements must represent the honest opinions and actual experience of the endorser, and any material connection between the advertiser and the endorser must be disclosed (FTC, 2023). The legal concern therefore focuses on misleading omissions rather than the mere fact that a product or benefit was provided.

A comparable situation exists in the pharmaceutical industry. Pharmaceutical companies often fund research, conferences, or speaking engagements where doctors discuss particular medications. These relationships are not automatically unlawful, but regulators require transparency about financial relationships. In the United States this is addressed through the Physician Payments Sunshine Act, which requires pharmaceutical companies to publicly disclose payments or benefits given to physicians so potential conflicts of interest are visible.

From a marketing perspective, influencer or expert endorsements can also be understood through the source credibility model, which suggests that consumers evaluate persuasive messages based on the perceived expertise and trustworthiness of the communicator (Hovland & Weiss, 1951). If the individual providing the recommendation genuinely uses the product and has relevant expertise, their opinion may still be persuasive even when compensation is involved. Similarly, research on influencer marketing suggests that transparency does not necessarily eliminate persuasion but may instead strengthen credibility when audiences perceive the relationship as honest (De Veirman et al., 2017).

Psychological theory also shows that audiences do not assume complete independence in commercial communication. According to the persuasion knowledge model, consumers generally recognise that endorsements often involve commercial relationships and adjust their interpretation of the message accordingly (Friestad & Wright, 1994). In this sense, disclosure allows consumers to evaluate the endorsement more critically rather than automatically rejecting it.

Applying these perspectives to the Carolina Pad case, providing products to bloggers could be interpreted as a common marketing practice similar to product sampling or expert endorsement. The key issue would therefore be whether bloggers disclose that they received the products and whether their opinions are thier genuine product experience.

So a broader question that connects legal, marketing, and psychological perspectives. If an influencer or professional genuinely uses a product and believes in it, does the fact that they are compensated automatically undermine the truth of what they say, or does compensation simply formalise a relationship that might exist because they already value the product? In other words, are consumers primarily concerned with whether the endorsement is paid, or with whether the experience being described is authentic?



References

De Veirman, M., Cauberghe, V., & Hudders, L. (2017). Marketing through Instagram influencers. International Journal of Advertising, 36(5), 798–828.

Friestad, M., & Wright, P. (1994). The persuasion knowledge model. Journal of Consumer Research, 21(1), 1–31.

Hovland, C. I., & Weiss, W. (1951). The influence of source credibility on communication effectiveness. Public Opinion Quarterly, 15(4), 635–650.

Federal Trade Commission. (2023). Guides concerning the use of endorsements and testimonials in advertising.

Physician Payments Sunshine Act, 42 U.S.C. §1320a–7h (2010).